![Credit Card 160×600 [EN]](https://dcgreferral.com/wp-content/uploads/2024/05/US-Japan-and-German-April-Consumer-Confidence-Rebound-Orbex.webp.webp)
Similar Posts
Difficult Session for Chinese Stock Market and Currency – Currency Thoughts
Difficult Session for Chinese Stock Market and Currency January 3, 2025 The dollar in offshore trading advanced to somewhat above 7.35 yuan, depressing China’s currency to an 18-year low, and the Shanghai Composite equity index tumbled 1.6% after officials let China’s 10-year interest rate slide below previous support levels. Against other currencies, the dollar is…
ASIC Permanently Bans Former Financial Adviser After $4.5m Fraud Conviction
The Australian Securities and Investments Commission (ASIC) said Friday that it has permanently banned former financial adviser Anthony Joseph Del Vecchio following his conviction for misappropriating more than $4.4 million from clients, family, and friends. Del Vecchio, who worked at Freedom Finance Australia from 2016 until 2023, was found guilty in April of 24 counts…
Nvidia (NVDA) Shares Consolidating Below $150
On October 22, while analysing Nvidia (NVDA) stock charts, we noted: → The stock had reached the $140 level;→ A long-term ascending channel (shown in blue) was mapped;→ Potential for price growth along the Quarter Line was suggested, dividing the lower half of the channel. Bullish sentiment remains around Nvidia, one of the leading stocks…
EUR/USD Holds Steady as US Government Shutdown Ends
By RoboForex Analytical Department The EUR/USD pair is trading flat on Thursday, hovering around 1.1587, following the House of Representatives’ approval of a short-term budget bill that ends the longest US government shutdown in history. The bill now awaits President Donald Trump’s signature – a formality that will allow shuttered government agencies to resume operations…
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth quarter…
